Retatrutide is a synthetic, long-acting peptide with triple agonist activity at GLP-1, GIP, and glucagon receptors, developed for controlled laboratory investigation of incretin signaling pathways and metabolic regulation mechanisms. This modified peptide has been studied for its unique receptor binding profiles, intracellular signaling cascade activation, and effects on glucose homeostasis and lipid metabolism in preclinical models.
Research Applications:
- Multi-receptor agonist pharmacology and binding kinetics studies
- GLP-1, GIP, and glucagon receptor pathway characterization
- Metabolic signaling pathway investigation in cellular models
- Insulin secretion and glucose homeostasis mechanism research
- Receptor selectivity and downstream effector analysis
- Peptide stability and degradation pathway studies (HPLC/LC-MS)
Specifications:
- Purity: >98% (HPLC verified)
- Molecular Weight: ~4.5 kDa (modified peptide)
- CAS Number: Not yet assigned (investigational compound)
- Supplied as: Lyophilized powder in sealed vials
- Available doses: 5mg, 10mg, 20mg, 30mg
- Storage: -20°C, protect from light and moisture
- Each batch includes Certificate of Analysis (COA)
Manufactured with strict quality standards to ensure consistency across experimental conditions and reproducibility in laboratory research.
For laboratory research use only. Not for human consumption.
Reviews
There are no reviews yet.